Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say
Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.
Source: marketwatch.com
Stay updated with breaking news from Stephen Morehouse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.
On each cross, the names and titles of soldiers from all around the state of Michigan killed in the line of duty.